These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 27256725)

  • 1. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study].
    Wu WL; Yan BY; Lyu JJ; Liu JY; Feng Y; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):484-90. PubMed ID: 27256726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
    Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults].
    Feng Y; Yan BY; Zhang L; Lü JJ; Liu JY; Gong XH; Cui FQ; Liang XF; Chen SY; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):813-7. PubMed ID: 23157885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up].
    Zhang L; Zhang W; Lyu JJ; Zhang JJ; Liu JY; Yan BY; Feng Y; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1156-1160. PubMed ID: 28910922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-HBs persistence after primary vaccination with three doses of 5 μg recombinant hepatitis B vaccine among normal and high-responder infants: 10-year of follow-up].
    Meng X; Lyu JJ; Feng Y; Dou X; Zhao X; Liang XF; Wang FZ; Xu AQ; Yan BY; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):794-799. PubMed ID: 35785861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Kong Q; Wu WL; Feng Y; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):497-502. PubMed ID: 31091608
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of booster dose vaccination 21- to 32-years after primary vaccination with hepatitis B vaccine in the population born from 1986 to 1996 in Zhengding County of Hebei Province].
    Zhang XJ; Wu ZW; Zhang YH; Li MJ; Zhou HS; Han BH; Hao ZY; Chu J; Gao Z; Ma JC; Zhao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):942-946. PubMed ID: 32907282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibodies persistence after revaccination with three doses of hepatitis B vaccine in non-responsive adults: results from 8-year follow-up study].
    Yan BY; Lyu JJ; Feng Y; Cao CZ; Meng X; Liang XF; Wang FZ; Xu AQ; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1546-1552. PubMed ID: 34814582
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness four years after Homo/Hetero prime-boost with 10 μg HP and 20 μg CHO recombinant hepatitis B vaccine at 1 and 6 months in maternal HBsAg-negative children.
    Yin Z; Wen T; Fu C; Li J; Fang Q; Gong X; You J; Wang S; Zheng C
    Front Immunol; 2024; 15():1308238. PubMed ID: 38660313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
    Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
    Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine].
    Liu J; Lyu J; Yan B; Feng Y; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Oct; 35(10):1091-4. PubMed ID: 25567010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of rapid hepatitis B vaccination with different vaccine dosages and types in adults].
    Nie L; Pang XH; Zhang Z; Ma JX; Liu XY; Qiu Q; Liang Y; Li Q; Zhang W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1151-1155. PubMed ID: 28910921
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison on the antibody response after primary immunization of 5 µg and 10 µg hepatitis B vaccine made by recombinant DNA techniques among newborns].
    Zhang L; Zhang W; Zhai XJ; Li YP; Li J; Yan BY; Li YT; Zhu FC; Huang T; Li LQ; Gong XH; Cui FQ; Liang XF; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):305-8. PubMed ID: 22613384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.